Companion animal vaccine Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2021 to 2027

Companion animal vaccines play an important role in ensuring longevity and health and improving the overall productivity of your pets in a cost-effective manner. Companion animal vaccines reduce the spread of various diseases from animals to humans.

Companion animal vaccine market is estimated to be valued at US$ 2,847.7 million in 2020 and is expected to exhibit a CAGR of 6% over the forecast period (2021-2027).

Key Players

Major players operating in the global companion animal vaccine market are Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva, Merck & Co., Inc., Virbac, Zoetis Inc., HIPRA, Biogénesis Bagó, and Ourofino Animal Health.


By Product Type:

  • Attenuated Live Vaccine,
  • Conjugate Vaccine,
  • Inactivated Vaccine,
  • Subunit Vaccine,
  • Toxoid Vaccine,
  • DNA Vaccine,
  • Recombinant Vaccine.

By Animal Type:

  • Canine,
  • Feline,
  • Equine,
  • Others

Scope of the Report

The research study analyzes the global Companion animal vaccine industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Companion animal vaccine Market Report

1. What was the Companion animal vaccine Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027).

2. What will be the CAGR of Companion animal vaccine Market during the forecast period (2021-2027)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
4. Which manufacturer/vendor/players in the Companion animal vaccine Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

The report will be delivered within 48-72 hours after payment confirmation